Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

27

Revenue 2017

Gilenya

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Gilenya was produced by Novartis.

Final NICE backing for Biogen Idec's Tecfidera

Final NICE backing for Biogen Idec's Tecfidera MS. It makes Tecfidera is the third oral MS drug recommended for NHS use, following 2012 guidance for Novartis' Gilenya (fingolimod) and a recommendation at the beginning of this year for

FDA approves Biogen Idec's long-acting MS therapy

FDA approves Biogen Idec's long-acting MS therapy The advent of the oral therapies for MS - which include not only Tecfidera but also Novartis' Gilenya (fingolimod) and Sanofi's Aubagio (teriflunomide) - is expected to shrink the beta interferon market,

Rebif hit again as competition bites

Rebif hit again as competition bites Biogen Idec's Tecfidera (dimethyl glutamate) and Novartis' Gilenya (fingolimod).

Novartis' vaccine sales decline ahead of GSK transfer

Novartis' vaccine sales decline ahead of GSK transfer The company's stable of growth products - such as oral multiple sclerosis (MS) therapy Gilenya (fingolimod) and cancer drugs Afinitor (everolimus) and Tasigna (nilotinib) - collectively contributed $3.4bn in revenues, up ... Particularly in Europe,

NICE green light for Biogen’s oral MS drug

NICE green light for Biogen’s oral MS drug The decision means that Tecfidera is set to become the third oral MS drug recommended by NICE, joining Novartis' Gilenya (fingolimod) and Sanofi's Aubagio (teriflunomide). ... Gilenya was the first oral MS drug to hit the European market in 2012, and it

[ Previous 5 results ] 5 6 7 8 9 10 11 12 13 14 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...

Latest intelligence

CHECKLIST 04: Let’s make your patient recruitment strategies a success
From how to generate insights to define your audience to drilling down those all-important key messages, our checklist has everything you need to think of, covered....
Multichannel engagement and the need for greater understanding of European markets
By Laurence Olding and Georgina James...
A snapshot of… Exscientia
...

Infographics